Correlation Between Kalvista Pharmaceuticals and RenovoRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and RenovoRx, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and RenovoRx.

Diversification Opportunities for Kalvista Pharmaceuticals and RenovoRx

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kalvista and RenovoRx is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and RenovoRx go up and down completely randomly.

Pair Corralation between Kalvista Pharmaceuticals and RenovoRx

Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 4.01 times less return on investment than RenovoRx. But when comparing it to its historical volatility, Kalvista Pharmaceuticals is 1.92 times less risky than RenovoRx. It trades about 0.03 of its potential returns per unit of risk. RenovoRx is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  65.00  in RenovoRx on August 27, 2024 and sell it today you would earn a total of  64.00  from holding RenovoRx or generate 98.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kalvista Pharmaceuticals  vs.  RenovoRx

 Performance 
       Timeline  
Kalvista Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalvista Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
RenovoRx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

Kalvista Pharmaceuticals and RenovoRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalvista Pharmaceuticals and RenovoRx

The main advantage of trading using opposite Kalvista Pharmaceuticals and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.
The idea behind Kalvista Pharmaceuticals and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments